CD34+CELL YIELD ON DAY 1 OF APHERESIS PREDICTS TOTAL CD34+CELL MOBILIZATION, NEUTROPHIL RECOVERY, AND SURVIVAL AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA

被引：0
|
作者：
Dean, R. [1 ]
Rybicki, L. [1 ]
Pohlman, B. [1 ]
Sweetenham, J. [1 ]
Sobecks, R. [1 ]
Copelan, E. [1 ]
Kalaycio, M. [1 ]
Smith, S. [1 ]
andresen, S. [1 ]
Bolwell, B. [1 ]
机构：
[1] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2009年 / 15卷 / 02期
关键词：
D O I：
10.1016/j.bbmt.2008.12.115
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
93
引用
收藏
页码：38 / 38
页数：1
相关论文
共 50 条
  • [21] Addition of plerixafor for CD34+cell mobilization in six healthy stem cell donors ensured satisfactory grafts for transplantation
    Hauge, Anne Werner
    Haastrup, Eva Kannik
    Sengelov, Henrik
    Minulescu, Lia
    Dickmeiss, Ebbe
    Fischer-Nielsen, Anne
    TRANSFUSION, 2014, 54 (04) : 1055 - 1058
  • [22] Optimizing the CD34+Cell Dose for Allogeneic Transplantation.
    Mehta, J.
    Evens, Andrew M.
    Altman, J.
    Frankfurt, O.
    Tallman, Martin
    Gordon, L.
    Williams, S.
    Winter, J.
    Krishnamurthy, J.
    Duffey, S.
    Singh, V.
    Meagher, R.
    Singhal, S.
    BLOOD, 2008, 112 (11) : 408 - 409
  • [23] Efficacy And Safety Of Pegfilgrastim For CD34+Cell Mobilization In Healthy Volunteers
    Goto, Hideki
    Hayasaka, Koji
    Sunagoya, Kana
    Michimata, Rie
    Nishida, Mutsumi
    Jingu, Maki
    Ichihashi, Yuki
    Odera, Mitsuhiko
    Hino, Masayuki
    Maeda, Yoshinobu
    Sawa, Masashi
    Teshima, Takanori
    BONE MARROW TRANSPLANTATION, 2021, 56 (SUPPL 1) : 177 - 179
  • [24] CD34+enriched cell products intended for autologous transendocardial CD34+cell transplantation release significant amounts of angiopoietin-1
    Rozman, J- Z.
    Jez, M.
    Malicev, E.
    Krasna, M.
    Vrtovec, B.
    Cukjati, M.
    Rozman, P.
    TRANSFUSION CLINIQUE ET BIOLOGIQUE, 2019, 26 (04) : 273 - 278
  • [25] CLINICAL USE OF PERIPHERAL BLOOD CD34+CELL COUNT AND MIDPOINT COLLECTION CD34+CELL YIELD FOR PERIPHERAL BLOOD STEM CELL COLLECTIONS FROM AUTOLOGOUS PATIENTS MOBILIZED BY G-CSF AND PLERIXAFOR
    Chepovetsky, J.
    Choo, Y. S.
    Blouin, A.
    Tindle, S.
    Bertinelli, A.
    Nash, E. M.
    Wu, D. W.
    VOX SANGUINIS, 2013, 105 : 293 - 294
  • [26] CD34+cell dose and CMV viremia after haploidentical hematopoietic stem cell transplantation: a retrospective study
    Yan, Peirou
    Pan, Xinan
    Hao, Qi
    Wang, Jingbo
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2024, 16 (09): : 5130 - 5136
  • [27] CD34+Cell Subsets in Stem Cell Products and Their Relationship with Engraftment Kinetics
    Kucukgode, Gizem Ertepe
    Ipek, Senay
    Yildirim, Yasin
    Gozukara, Melih Gaffar
    Dalva, Klara
    Seval, Guldane Cengiz
    Bozdag, Sinem Civriz
    Toprak, Selami Kocak
    Yuksel, Meltem Kurt
    Ilhan, Osman
    Topcuoglu, Pervin
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 688 - 689
  • [28] The predictive value of white cell or CD34+cell count in the peripheral blood for timing apheresis and maximizing yield
    Yu, J
    Leisenring, W
    Bensinger, WI
    Holmberg, LA
    Rowley, SD
    TRANSFUSION, 1999, 39 (05) : 442 - 450
  • [29] Influence of plerixafor on the mobilization of CD34+cell subpopulations and lymphocyte subtypes
    Worel, Nina
    Frank, Nelli
    Frech, Christian
    Fritsch, Gerhard
    TRANSFUSION, 2017, 57 (09) : 2206 - 2215
  • [30] CD34+cell dose is an independent prognostic factor in patients with Hodgkin lymphoma and multiple myeloma who underwent autologous stem cell transplantation
    Balint, M. Todorovic
    Jelicic, J.
    Bila, J.
    Vujic, D.
    Balint, B.
    Kurtovic, N. Kraguljac
    Sefer, D.
    Serbic, O.
    Lazic, E.
    Antic, D.
    Andjelic, B.
    Smiljanic, M.
    Sretenovic, A.
    Mihaljevic, B.
    BONE MARROW TRANSPLANTATION, 2017, 52 : S463 - S463
12345